Related Experiment Video
Updated: May 8, 2026
05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Secondary amyloidosis in Indigenous Australians.
1Palliative Care Service, Broadmeadows Health Service, Victoria Department of Renal Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Internal Medicine Journal
|September 12, 2013
Summary
Secondary amyloidosis (AA) is a complication of chronic inflammation, often linked to rheumatological disease in developed nations. This case series highlights its occurrence and varied causes in Indigenous Australians, including bronchiectasis.
Area of Science:
- Nephrology
- Rheumatology
- Pathology
Background:
- Secondary amyloidosis (AA) is a known complication of chronic inflammatory diseases.
- Rheumatological conditions are the most frequent cause of AA in developed countries.
- The spectrum of underlying causes for AA may differ in distinct populations, such as Indigenous communities.
Observation:
- This study presents a case series of three Indigenous Australians living in remote areas.
- All three patients were diagnosed with pathologically confirmed amyloidosis and renal impairment.
- An underlying inflammatory condition was not apparent in two of the cases.
Findings:
- One patient with established bronchiectasis experienced rapid renal function decline at a young age.
- The varied presentation underscores the need for careful evaluation of AA causes in Indigenous populations.
- Amyloidosis diagnosis in this cohort was associated with significant renal impairment.
Implications:
- This case series suggests that the etiology of secondary amyloidosis may vary in Indigenous Australian populations.
- Further research is warranted to understand the specific drivers and risk factors for amyloidosis in these communities.
- Early recognition and management of underlying inflammatory conditions are crucial for preventing renal complications associated with amyloidosis.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...